Hodgkin DiseaseLymphomaLymphoma, Non-HodgkinAntineoplastic Combined Chemotherapy ProtocolsLymphoma, B-CellLymphoma, Large B-Cell, DiffuseLymphoma, T-CellReed-Sternberg CellsCarcinoma, Large CellLymphoma, FollicularChemotherapy, AdjuvantAntigens, CD30Burkitt LymphomaLymphoma, B-Cell, Marginal ZoneDoxorubicinCyclophosphamideCombined Modality TherapyLymphoma, AIDS-RelatedLymphoma, T-Cell, PeripheralAntineoplastic AgentsLymphoma, T-Cell, CutaneousTreatment OutcomeLymphoma, Large-Cell, AnaplasticLymphoma, Mantle-CellCarcinoma, NeuroendocrineBleomycinPrognosisLung NeoplasmsNeoplasm StagingEtoposideDisease-Free SurvivalCisplatinLymphoma, Large-Cell, ImmunoblasticVincristineSurvival RateSurvival AnalysisVinblastineImmunohistochemistryPrednisoneTranslocation, GeneticAntigens, CD20Fatal OutcomeTumor Markers, BiologicalMethotrexateHerpesvirus 4, HumanAntibodies, Monoclonal, Murine-DerivedEpstein-Barr Virus InfectionsNeoadjuvant TherapyDacarbazineImmunophenotypingLymph NodesTransplantation, AutologousSalvage TherapyBreast NeoplasmsReceptor Protein-Tyrosine KinasesCell Line, TumorAntibodies, MonoclonalNeoplasm Recurrence, LocalLymphoma, Primary Cutaneous Anaplastic Large CellDrug Administration ScheduleFollow-Up StudiesCytarabineProto-Oncogene Proteins c-bcl-6NeoplasmsRecurrenceB-LymphocytesChromosomes, Human, Pair 2Mediastinal NeoplasmsTime FactorsProcarbazineDrug Resistance, NeoplasmAdenocarcinomaGene Expression Regulation, NeoplasticRadiotherapyTumor Cells, CulturedCarcinoma, Non-Small-Cell LungCarboplatinIfosfamideLymphomatoid PapulosisPaclitaxelGene RearrangementHematopoietic Stem Cell TransplantationSkin NeoplasmsInduction ChemotherapyDNA, NeoplasmNeoplasm ProteinsBiopsyMycosis FungoidesNeoplasms, Second PrimaryAntineoplastic Agents, AlkylatingProtein-Tyrosine KinasesDeoxycytidineKaplan-Meier EstimateLeukemia, Lymphocytic, Chronic, B-CellAnthracyclinesTaxoidsRetrospective StudiesApoptosisLymphoproliferative DisordersPolymerase Chain Reaction